[Safety analysis of Allergovit immunotherapy in patients of allergic rhinitis].

Abstract

OBJECTIVE:

To analyse the safety of Allergovit immunotherapy in patients of allergic rhinitis.

METHOD:

Two hundred and fifty-six patients with allergic rhinitis received Allergovit immunotherapy, their local and systemic side-effect were observed, recorded and analyzed during the treatment.

RESULT:

The number of patients who got local side-effect was 84 cases, the percent of local side-effect was 4.45%; the number of patients who got systemic side-effect were 21 cases, the percent of systemic side-effect was 0.31%. Both side-effects were slight.

CONCLUSION:

Allergovit immunotherapy is a safe and feasible choice for allergic rhinitis. While the schedule fit for Chinese or individually is needed to be mended in practice.

• Authors: Jianjun Chen, Jisheng Xiang, Weijia Kong, Hong Shu, Qiumei Shi, Huifang Tan
• Journal: Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology (Lin Chuang Er Bi Yan Hou Ke Za Zhi) Vol. 20 Issue 5 Pg. 208-9 (Mar 2006) China
• PMID: 16722392 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Vaccines
• allergovit

Topics

• Adolescent
• Adult
• Asthma (therapy)
• Child
• Child, Preschool
• Desensitization, Immunologic (adverse effects, methods)
• Female
• Humans
• Hypersensitivity, Immediate (therapy)
• Male
• Rhinitis, Allergic, Seasonal (therapy)
• Vaccines (adverse effects, therapeutic use)
• Young Adult